Maria E. Cabanillas
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Thyroid Cancer Diagnosis and Treatment, Cancer-related Molecular Pathways, BRCA gene mutations in cancer, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Thyroid cancer(2016)1,424 cited
- → Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer(2017)860 cited
- → Efficacy of Selpercatinib in RET -Altered Thyroid Cancers(2020)741 cited
- → 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer(2021)671 cited
- → Selective RET kinase inhibition for patients with RET-altered cancers(2018)426 cited
- → Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial(2016)381 cited
- → Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019(2020)368 cited
- → Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond(2019)326 cited
- → Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study(2022)325 cited